TYMLOS

To Evaluate the Efficacy and Safety of Abaloparatide Injection (QLG2128) in the Treatment of Postmenopausal Women With Osteoporosis and at High Risk of Fracture

Supracondylar Distal Femur Fractures and Abaloparatide

Real-world Effectiveness and Cardiovascular Safety Study of Abaloparatide in Postmenopausal Women

Abaloparatide Added to Ongoing Denosumab vs Continued Denosumab Alone

Study to Evaluate and Compare the Bioequivalence of Two Abaloparatide-sMTS Treatments in Healthy Women.